查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1451760

2024-2032 年按年齡層別類型、應用、配銷通路和地區分類的女性健康市場報告

Women's Health Market Report by Age Group Type, Application, Distribution Channel, and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 142 Pages | 商品交期: 2-3個工作天內

價格

2023年，全球女性健康市場規模達到410億美元。展望未來， IMARC Group預計到2032年市場規模將達到579億美元，2024-2032年複合年成長率（CAGR）為3.78%。老年婦女人口不斷成長，與老化相關的特定健康需求，不斷變化的社會規範和對婦女健康的態度，以及為更好地獲得醫療服務而增加的資金是推動市場的一些主要因素。

女性健康是指專注於治療和診斷影響女性身心健康的疾病和狀況的醫學分支。它涵蓋廣泛的專業和重點領域，例如生殖健康、孕產婦健康、心理健康和非傳染性疾病，這些都會對婦女產生重大影響。它不僅對婦女的個人福祉至關重要，而且對經濟生產力、家庭穩定和公共衛生結果也具有更廣泛的社會影響。此外，值得注意的是，這些問題受到生物因素以及社會規範、生活方式選擇和醫療保健方面與性別相關的差異的影響。因此，對婦女健康採取全面的方法需要理解和解決這些多方面的問題。

女性人口老化是女性健康市場的主要驅動力。隨著女性年齡的成長，她們面臨一系列特定的健康挑戰，包括更年期、骨質疏鬆症、心臟病和某些類型的癌症。全球老年婦女人口不斷增加，以及與老化相關的特定健康需求，對服務和產品產生了強勁的需求。除此之外，不斷變化的社會規範和對女性健康的態度也成為該行業的重要推動力。因此，人們對權利的日益認知和對針對性別的醫療保健的需求正在對市場產生積極影響。此外，全球醫療保健支出的成長也大大促進了女性健康市場的成長。隨著收入水準的提高，個人和家庭更傾向於投資於預防性和治療性醫療保健。各國政府也將大部分預算用於醫療保健。這種加速資助可以讓人們更好地獲得醫療保健服務，並促進婦女醫療保健研究和產品開發的進步。

女性健康市場趨勢/促進因素：

提高意識和政府舉措

在過去的幾年裡，全球各國政府、非營利組織和國際機構在提高人們對婦女健康議題的認知方面發揮了重要作用。這主要是透過運動、政策變革以及研究和服務資助來實現的。這些措施創造了一個健康問題受到全球關注的環境，導致對婦女健康產品和服務的需求增加。此外，這些政府措施通常包括健康檢查、診斷測試和預防措施的規定，這進一步推動了該行業的成長。例如，各種政府法案為強制性健康保險規定提供預防性服務，從而擴大了對此類服務的需求。

科技不斷進步

科技的快速進步對女性健康產業產生了重大影響。同時，診斷工具和治療方法也不斷發展和改進，從而實現了更好的疾病檢測、更有效的治療並提高了存活率。遠距醫療、行動應用程式和穿戴式裝置等數位健康科技現在正在幫助女性更有效地追蹤和管理自己的健康狀況。包括人工智慧和機器學習在內的先進技術也被應用於各種相關問題的診斷和治療。這些技術進步確保為女性提供更有效和個人化的醫療保健解決方案，同時也透過創造新的機會和需求來刺激市場的成長。

慢性病發生率上升

女性慢性疾病的發生率不斷增加，例如癌症（特別是乳癌和子宮頸癌）、心血管疾病、糖尿病和骨質疏鬆症，推動了對這些服務的需求。據全球衛生組織稱，非傳染性疾病，特別是癌症和心血管疾病，是造成全球女性死亡的主要原因。同時，女性慢性病發病率的驚人上升需要及時發現、有效的治療方案和加強預防性護理，這是女性健康產業的主要推動力。此外，生殖健康仍然是市場的一個重要面向。該行業越來越重視計劃生育服務、產前護理和安全分娩實踐，以降低孕產婦和嬰兒死亡率，進一步影響市場。

目錄

第1章：前言

第 2 章：範圍與方法

  • 研究目的
  • 利害關係人
  • 資料來源
    • 主要資源
    • 二手資料
  • 市場預測
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第 3 章：執行摘要

第 4 章：簡介

  • 概述
  • 主要行業趨勢

第 5 章：全球女性健康市場

  • 市場概況
  • 市場業績
  • COVID-19 的影響
  • 市場預測

第 6 章：市場區隔：依年齡段

  • 50歲以上
    • 市場走向
    • 關鍵環節
      • 停經後骨質疏鬆症
      • 子宮內膜異位症和子宮肌瘤
      • 停經
    • 市場預測
  • 其他
    • 市場走向
    • 市場預測

第 7 章：市場區隔：按應用

  • 避孕藥具
    • 市場走向
    • 市場預測
  • 骨質疏鬆症
    • 市場走向
    • 市場預測
  • 停經
    • 市場走向
    • 市場預測
  • 不孕症
    • 市場走向
    • 市場預測
  • 其他
    • 市場走向
    • 市場預測

第 8 章：市場區隔：按配銷通路

  • 醫院藥房
    • 市場走向
    • 市場預測
  • 零售藥局
    • 市場走向
    • 市場預測
  • 網路藥局
    • 市場走向
    • 市場預測

第 9 章：市場區隔：按地區

  • 北美洲
    • 美國
      • 市場走向
      • 市場預測
    • 加拿大
      • 市場走向
      • 市場預測
  • 亞太
    • 中國
      • 市場走向
      • 市場預測
    • 日本
      • 市場走向
      • 市場預測
    • 印度
      • 市場走向
      • 市場預測
    • 韓國
      • 市場走向
      • 市場預測
    • 澳洲
      • 市場走向
      • 市場預測
    • 印尼
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 歐洲
    • 德國
      • 市場走向
      • 市場預測
    • 法國
      • 市場走向
      • 市場預測
    • 英國
      • 市場走向
      • 市場預測
    • 義大利
      • 市場走向
      • 市場預測
    • 西班牙
      • 市場走向
      • 市場預測
    • 俄羅斯
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 拉丁美洲
    • 巴西
      • 市場走向
      • 市場預測
    • 墨西哥
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 中東和非洲
    • 市場走向
    • 市場細分：按國家/地區
    • 市場預測

第 10 章：促進因素、限制與機會

  • 概述
  • 促進要素
  • 限制
  • 機會

第 11 章：價值鏈分析

第 12 章：波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第 13 章：價格分析

第14章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • Abbott Laboratories
    • AbbVie Inc.
    • Agile Therapeutics Inc.
    • Amgen Inc.
    • Bayer AG
    • F. Hoffmann-La Roche AG
    • Ferring Pharmaceuticals
    • FUJIFILM Holdings Corporation
    • Hologic Inc.
    • Lupin Limited
    • Novo Nordisk A/S
    • Pfizer Inc.
Product Code: SR112024A7615

The global women's health market size reached US$ 41.0 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 57.9 Billion by 2032, exhibiting a growth rate (CAGR) of 3.78% during 2024-2032. The growing population of elderly women, and the specific health needs associated with aging, changing societal norms and attitudes towards women's health, and the rising funding for better access to healthcare services are some of the major factors propelling the market.

Women's health refers to the branch of medicine that focuses on the treatment and diagnosis of diseases and conditions that affect a woman's physical and emotional well-being. It encompasses a broad range of specialties and focus areas, such as reproductive health, maternal health, mental health, and non-communicable diseases, which can all significantly impact women. It is vital not only for the individual well-being of women, but it also has wider societal implications relating to economic productivity, family stability, and public health outcomes. Furthermore, it's important to note that these issues are influenced by biological factors as well as gender-related differences in societal norms, lifestyle choices, and access to healthcare. Thus, a comprehensive approach to women's health necessitates understanding and addressing these multifaceted dimensions.

The aging female population is a key driver of the women's health market. As women age, they face a specific set of health challenges including menopause, osteoporosis, heart disease, and certain types of cancer. This increasing population of elderly women globally, and the specific health needs associated with aging, create a robust demand for services and products. Along with this, changing societal norms and attitudes towards women's health have also acted as a significant driver in this industry. Therefore, the growing recognition of rights and the need for gender-specific healthcare is positively influencing the market. In addition, the rise in healthcare spending across the globe also contributes significantly to the growth of the women's health market. With higher income levels, individuals and families are more inclined to invest in preventive and curative healthcare. Governments, too, are dedicating larger portions of their budgets towards healthcare. This accelerated funding allows for better access to healthcare services and promotes advancements in women's healthcare research and product development.

Women's Health Market Trends/Drivers:

Increased Awareness and Government Initiatives

Over the past few years, governments across the globe, non-profit organizations, and international agencies have played an instrumental role in heightening awareness about women's health issues. This has been primarily achieved through campaigns, policy changes, and funding for research and services. These initiatives have fostered an environment where health matters are gaining global attention, leading to increased demand for women's health products and services. Moreover, these government initiatives often include provisions for health screenings, diagnostic tests, and preventive measures, which further drive the growth of the industry. Various government acts, for instance, make preventative services for a mandatory health insurance provision, amplifying the demand for such services.

Continuous Advancements in Technology

The rapid advancement in technology has significantly impacted the women's health industry. Along with this, diagnostic tools and therapies have evolved and improved, which have led to better disease detection, more effective treatments, and increased survival rates. Digital health technologies, such as telehealth, mobile apps, and wearable devices are now assisting women in tracking and managing their health more efficiently. Advanced technologies, including artificial intelligence and machine learning, are also being employed in the diagnosis and treatment of various related issues. These technological advancements ensure more effective and personalized healthcare solutions for women but also stimulate the market's growth by creating new opportunities and demands.

Rising Incidences of Chronic Diseases

An increasing incidence of chronic diseases among women, such as cancer (specifically breast and cervical cancer), cardiovascular diseases, diabetes, and osteoporosis, is driving the need for these services. According to global health organizations, non-communicable diseases, notably cancer, and cardiovascular diseases, are responsible for the majority of deaths among women across the globe. In confluence with this, this alarming rise in chronic conditions among women necessitates timely detection, effective treatment options, and increased preventive care, which are the major propellers for the women's health industry. Also, reproductive health remains a significant aspect of the market. The industry is witnessing a growing emphasis on access to family planning services, prenatal care, and safe childbirth practices to reduce maternal and infant mortality rates, further impacting the market.

Women's Health Industry Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global women's health market report, along with forecasts at the global, regional and country levels from 2024-2032. Our report has categorized the market based on age group type, application and distribution channel.

Breakup by Age Group Type:

50 Years and Above

Postmenopausal Osteoporosis

Endometriosis and Uterine Fibroids

Menopause

Others

50 Years and Above dominate the market

The report has provided a detailed breakup and analysis of the market based on the age group type. This includes 50 years and above (postmenopausal osteoporosis, endometriosis and uterine fibroids, and menopause), and others. According to the report, 50 years and above represented the largest segment.

The 50 years and above age group in the industry has witnessed significant market drivers over the past decades. One of the primary factors contributing to this trend is the global demographic shift towards an aging population, leading to an increased number of women entering this age bracket. Additionally, advancements in healthcare technology and increased access to medical services have enabled better diagnoses and treatments for age-related health conditions in women. In addition, the growing awareness among this demographic regarding preventive healthcare measures and wellness has influenced the demand for specialized products and services catering to their unique needs. As women in this age group seek to maintain their health and quality of life, there is an escalating demand for menopause-related treatments, bone health supplements, and preventive screenings. This market segment's potential for growth is further bolstered by the expanding focus on research, allowing the industry to offer targeted and evidence-based solutions.

Breakup by Application:

Contraceptives

Osteoporosis

Menopause

Infertility

Others

Contraceptives dominate the market

A detailed breakup and analysis of the market based on the application have also been provided in the report. This includes contraceptives, osteoporosis, menopause, infertility, and others. According to the report, contraceptives represented the largest segment.

The industry has been significantly influenced by the increasing global awareness of family planning and reproductive health. Governments, organizations, and healthcare providers are emphasizing the importance of safe and effective contraceptive methods to empower women to make informed choices about their reproductive health. Additionally, advancements in medical technology have led to the development of a wide range of contraceptive options, offering women more choices and personalized solutions to suit their preferences and needs. In confluence with this, the shifting societal attitudes towards women's rights and gender equality have resulted in greater access to contraceptive products and services, enabling women to take control of their reproductive decisions. Furthermore, the growing prevalence of sexually transmitted infections has reinforced the importance of using contraceptives as a means of protection.

Breakup by Distribution Channel:

Hospital Pharmacies

Retail Pharmacies

Online Pharmacies

Hospital pharmacies dominate the market

The report has provided a detailed breakup and analysis of the market based on the distribution channel. This includes hospital pharmacies, retail pharmacies, and online pharmacies. According to the report, hospital pharmacies represented the largest segment.

The hospital pharmacies distribution channel in the industry is experiencing significant market drivers that shape its growth and development. One of the key factors contributing to the prominence of this distribution channel is the rising demand for specialized women's health medications and treatments within hospital settings. Hospitals serve as essential centers for comprehensive medical care, making them an ideal platform to provide a wide range of women's health products, including contraceptives, hormone therapies, fertility medications, and prenatal supplements. Additionally, the increasing prevalence of chronic conditions, such as gynecological disorders and menopause-related symptoms, has led to a growing need for prompt access to medications and treatments, which hospital pharmacies can efficiently cater to. Furthermore, regulatory initiatives and healthcare policies that encourage hospitals to maintain well-stocked pharmacies with a focus on women's health contribute to the expansion of this distribution channel.

Breakup by Region:

North America

United States

Canada

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Asia Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

North America exhibits a clear dominance, accounting for the largest market share

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.

The industry in North America is influenced by the region's aging population. It contributes to an increased demand for women's health services and products catering to menopausal and post-menopausal women. Additionally, the growing awareness and emphasis on preventive healthcare measures among women drive the market for screenings, wellness programs, and specialized treatments. In addition, advancements in medical research and technology facilitate the development of innovative solutions, encouraging investment and competition in the industry.

Moreover, favorable healthcare policies and insurance coverage for women's health services bolster market growth. Apart from this, shifting cultural attitudes towards women's empowerment and gender equality enhances access to comprehensive healthcare, including family planning and contraceptive options. Furthermore, strategic marketing efforts and educational campaigns by industry players to promote health and wellness further fuel market expansion.

Competitive Landscape:

The global women's health market is experiencing significant growth due to the growing investments in research and development to create new and improved women's health products, including contraceptives, fertility treatments, hormone therapies, prenatal vitamins, and other related medications. Along with this, companies are promoting their women's health products and services through marketing campaigns to grow awareness among healthcare providers and consumers. These campaigns often focus on promoting the benefits and efficacy of their offerings. Numerous companies are forming partnerships with healthcare providers, clinics, hospitals, and other organizations to expand their market reach and enhance distribution channels, impacting the market. Moreover, the introduction of educational programs for healthcare professionals to ensure proper understanding and usage of their products is contributing to the market.

The report has provided a comprehensive analysis of the competitive landscape in the global women's health market. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

Abbott Laboratories

AbbVie Inc.

Agile Therapeutics Inc.

Amgen Inc.

Bayer AG

Hoffmann-La Roche AG

Ferring Pharmaceuticals

FUJIFILM Holdings Corporation

Hologic Inc.

Lupin Limited

Novo Nordisk A/S

Pfizer Inc.

Recent Developments:

In June 2023, AbbVie Inc. revealed the names of the 20 amazing women business owners who will receive grants and mentoring from the IFundWomen and BOTOX(R) Cosmetic award programme.

In October 2021, Abbott Laboratories stated that it has signed a three-year contract to serve as the Real Madrid Football Club's Global Health Sciences and Nutrition Partner and Global Partner of the Real Madrid Foundation, whose mission is to spread the ideals of sport to adolescents all over the world. In addition to providing nutritional assistance for the inaugural men's and women's Academy teams as well as new product development, the alliance will also benefit at-risk youngsters in 80 countries via educational, sporting, and social welfare initiatives.

In June 2023, Agile Therapeutics Inc. stated that MMCAP Infuse Members would have access to the Twirla (levonorgestrel and ethinyl estradiol) transdermal system. The business anticipates that this improved supply will have a favorable effect on demand growth and factory sales in the non-retail channel, which climbed 20% and 15%, respectively, from the fourth quarter of 2022 to the first quarter of 2023.

Key Questions Answered in This Report:

  • How has the global women's health market performed so far, and how will it perform in the coming years?
  • What are the drivers, restraints, and opportunities in the global women's health market?
  • What is the impact of each driver, restraint, and opportunity on the global women's health market?
  • What are the key regional markets?
  • Which countries represent the most attractive women's health market?
  • What is the breakup of the market based on the age group?
  • Which is the most attractive age group in the women's health market?
  • What is the breakup of the market based on the application?
  • Which is the most attractive application in the women's health market?
  • What is the breakup of the market based on the distribution channel?
  • Which is the most attractive distribution channel in the women's health market?
  • What is the competitive structure of the global women's health market?
  • Who are the key players/companies in the global women's health market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Women's Health Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Age Group

  • 6.1 50 Years and Above
    • 6.1.1 Market Trends
    • 6.1.2 Key Segments
      • 6.1.2.1 Postmenopausal Osteoporosis
      • 6.1.2.2 Endometriosis and Uterine Fibroids
      • 6.1.2.3 Menopause
    • 6.1.3 Market Forecast
  • 6.2 Others
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Application

  • 7.1 Contraceptives
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Osteoporosis
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Menopause
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Infertility
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Others
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast

8 Market Breakup by Distribution Channel

  • 8.1 Hospital Pharmacies
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Retail Pharmacies
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Online Pharmacies
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 Drivers, Restraints, and Opportunities

  • 10.1 Overview
  • 10.2 Drivers
  • 10.3 Restraints
  • 10.4 Opportunities

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Abbott Laboratories
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 AbbVie Inc.
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 Agile Therapeutics Inc.
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
    • 14.3.4 Amgen Inc.
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 Bayer AG
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 F. Hoffmann-La Roche AG
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
    • 14.3.7 Ferring Pharmaceuticals
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
    • 14.3.8 FUJIFILM Holdings Corporation
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 Hologic Inc.
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis
    • 14.3.10 Lupin Limited
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis
    • 14.3.11 Novo Nordisk A/S
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
      • 14.3.11.3 Financials
      • 14.3.11.4 SWOT Analysis
    • 14.3.12 Pfizer Inc.
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio
      • 14.3.12.3 Financials
      • 14.3.12.4 SWOT Analysis

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

List of Figures

  • Figure 1: Global: Women's Health Market: Major Drivers and Challenges
  • Figure 2: Global: Women's Health Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Women's Health Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Women's Health Market: Breakup by Age Group (in %), 2023
  • Figure 5: Global: Women's Health Market: Breakup by Application (in %), 2023
  • Figure 6: Global: Women's Health Market: Breakup by Distribution Channel (in %), 2023
  • Figure 7: Global: Women's Health Market: Breakup by Region (in %), 2023
  • Figure 8: Global: Women's Health (50 Years and Above) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 9: Global: Women's Health (50 Years and Above) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 10: Global: Women's Health (Other Age Groups) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 11: Global: Women's Health (Other Age Groups) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 12: Global: Women's Health (Contraceptives) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: Women's Health (Contraceptives) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 14: Global: Women's Health (Osteoporosis) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 15: Global: Women's Health (Osteoporosis) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 16: Global: Women's Health (Menopause) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 17: Global: Women's Health (Menopause) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 18: Global: Women's Health (Infertility) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 19: Global: Women's Health (Infertility) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 20: Global: Women's Health (Other Applications) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Global: Women's Health (Other Applications) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 22: Global: Women's Health (Hospital Pharmacies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 23: Global: Women's Health (Hospital Pharmacies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 24: Global: Women's Health (Retail Pharmacies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 25: Global: Women's Health (Retail Pharmacies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 26: Global: Women's Health (Online Pharmacies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 27: Global: Women's Health (Online Pharmacies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 28: North America: Women's Health Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 29: North America: Women's Health Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 30: United States: Women's Health Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 31: United States: Women's Health Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 32: Canada: Women's Health Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 33: Canada: Women's Health Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 34: Asia-Pacific: Women's Health Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 35: Asia-Pacific: Women's Health Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 36: China: Women's Health Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 37: China: Women's Health Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 38: Japan: Women's Health Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 39: Japan: Women's Health Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 40: India: Women's Health Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 41: India: Women's Health Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 42: South Korea: Women's Health Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 43: South Korea: Women's Health Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 44: Australia: Women's Health Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 45: Australia: Women's Health Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 46: Indonesia: Women's Health Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 47: Indonesia: Women's Health Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 48: Others: Women's Health Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 49: Others: Women's Health Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 50: Europe: Women's Health Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 51: Europe: Women's Health Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 52: Germany: Women's Health Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 53: Germany: Women's Health Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 54: France: Women's Health Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 55: France: Women's Health Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 56: United Kingdom: Women's Health Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 57: United Kingdom: Women's Health Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 58: Italy: Women's Health Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 59: Italy: Women's Health Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 60: Spain: Women's Health Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 61: Spain: Women's Health Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 62: Russia: Women's Health Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 63: Russia: Women's Health Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 64: Others: Women's Health Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 65: Others: Women's Health Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 66: Latin America: Women's Health Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 67: Latin America: Women's Health Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 68: Brazil: Women's Health Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 69: Brazil: Women's Health Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 70: Mexico: Women's Health Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 71: Mexico: Women's Health Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 72: Others: Women's Health Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 73: Others: Women's Health Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 74: Middle East and Africa: Women's Health Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 75: Middle East and Africa: Women's Health Market: Breakup by Country (in %), 2023
  • Figure 76: Middle East and Africa: Women's Health Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 77: Global: Women's Health Industry: Drivers, Restraints, and Opportunities
  • Figure 78: Global: Women's Health Industry: Value Chain Analysis
  • Figure 79: Global: Women's Health Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Women's Health Market: Key Industry Highlights, 2023 & 2032
  • Table 2: Global: Women's Health Market Forecast: Breakup by Age Group (in Million US$), 2024-2032
  • Table 3: Global: Women's Health Market Forecast: Breakup by Application (in Million US$), 2024-2032
  • Table 4: Global: Women's Health Market Forecast: Breakup by Distribution Channel (in Million US$), 2024-2032
  • Table 5: Global: Women's Health Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 6: Global: Women's Health Market: Competitive Structure
  • Table 7: Global: Women's Health Market: Key Players